Results 91 to 100 of about 5,550 (180)

The JAK2 V617F mutation and thrombocytopenia

Hematology/Oncology and Stem Cell Therapy, 2017
Langabeer, Stephen E., Haslam, Karl
openaire   +2 more sources

Rescue balloon pulmonary angioplasty for worsening chronic thromboembolic pulmonary hypertension with essential thrombocythaemia and the JAK2-V617F mutation: a case report. [PDF]

Eur Heart J Case Rep, 2023
Tamura H, Hosokawa S, Yuba K, Kishi K.
europepmc   +1 more source

Absence of JAK2 V617F mutation in gastric cancers [PDF]

Acta Oncologica, 2006
Jong Woo, Lee, Young Hwa, Soung, Su Young, Kim, Suk Woo, Nam, Won Sang, Park, Jung Young, Lee, Nam Jin, Yoo, Sug Hyung, Lee   +7 more
openaire   +2 more sources

Neutrophilia and the JAK2 V617F Mutation

Pathology & Oncology Research, 2017
Stephen E, Langabeer, Karl, Haslam
openaire   +2 more sources

Low-level somatic JAK2 V617F mutation in myelodysplastic/myeloproliferative neoplasm with ring sideroblasts, and thrombocytosis with co-mutated SF3B1 and CALR. [PDF]

Blood Res, 2022
Ji YS, Park SK, Jeon BR, Jang MA.
europepmc   +1 more source

Efficacy of JAK1/2 inhibition in murine myeloproliferative neoplasms is not mediated by targeting oncogenic signaling

Nature Communications
Ruxolitinib is a potent JAK1/JAK2 inhibitor, approved for the treatment of primary myelofibrosis (PMF) patients based on the concept of inhibition of oncogenic signaling.
Sivahari Prasad Gorantla, Michael Rassner, Kirstyn Anne Crossley, Tony Andreas Müller, Teresa Poggio, Shifa Khaja Saleem, Helen Kleinfelder, Sudheer Madan Mohan Gambheer, Cornelia Endres, Sabina Schaberg, Dominik Schmidt, Gerin Prince, Irene Gonzalez-Menendez, Detlef Bentrop, Rainer Trittler, Svetlana Rylova, Dietmar Pfeifer, Geoffroy Andrieux, Leticia Quintanilla-Martinez, Anna Lena Illert, Nikolas von Bubnoff, Robert Zeiser, Justus Duyster   +22 more
doaj   +1 more source

Successful treatment for a patient with chronic thromboembolic pulmonary hypertension comorbid with essential thrombocythemia with the JAK2 V617F mutation by balloon pulmonary angioplasty. [PDF]

Respir Med Case Rep, 2020
Yamaguchi T, Izumiya Y, Hayashi H, Ichikawa Y, Ishikawa H, Shibata A, Yamazaki T, Yoshiyama M.   +7 more
europepmc   +1 more source

The JAK2 V617F mutation in breast cancer?

The Breast Journal, 2020
openaire   +2 more sources

Rapid postoperative platelet decline in a lung adenocarcinoma with sarcomatoid differentiation and concomitant JAK2 V617F mutation: a case report. [PDF]

Front Oncol
Deng L, Li X.
europepmc   +1 more source